KROS
Keros Therapeutics Inc.
$17.39
+$0.57(+3.39%)
63
Overall
60
Value
66
Tech
--
Quality
Market Cap
$500.56M
Volume
1.44M
52W Range
$9.12 - $72.37
Target Price
$23.25
Key Metrics Overview
| Market Cap | $500.56M | P/E Ratio | 9.06 |
| 52W High | $72.37 | 52W Low | $9.12 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | -25.7% | 52W Position | 13.1% |
| Overall Score | 63 | Value Score | 60 |
| Quality Score | -- | Technical Score | 66 |
Growth Analysis
| EPS Current Est | $1.92 | EPS Next Est | $-3.65 |
| EPS Growth Est | -290.1% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KROS | $17.39 | +3.4% | 1.44M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |